首页> 外文OA文献 >Effects of ribavirin on respiratory syncytial virus in vitro.
【2h】

Effects of ribavirin on respiratory syncytial virus in vitro.

机译:病毒唑对体外呼吸道合胞病毒的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ribavirin was demonstrated to have an antiviral effect on respiratory syncytial virus in vitro. A 50% reduction in plaque number was observed at concentrations of 3 or 10 micrograms of ribavirin per ml. This effect was observed when the drug was added as late as 12 h postinfection. At concentrations of greater than 10 micrograms of ribavirin per ml, the size of the syncytial plaque also noticeably decreased. Ribavirin similarly decreased the number of infectious units released into the culture supernatant. The antiviral effect was observed to be inversely related to the size of the viral inoculum, although all concentrations above 3.2 micrograms of ribavirin per ml visibly lessened the cytopathic effect regardless of the inoculum. Cloning of respiratory synctial virus in inhibitory concentrations of ribavirin failed to show increased resistance to the drug.
机译:已证明利巴韦林在体外对呼吸道合胞病毒具有抗病毒作用。在每毫升3或10微克的病毒唑浓度下,噬菌斑数量减少了50%。当在感染后12小时才添加药物时,观察到了这种效果。在每毫升大于10微克的利巴韦林浓度下,合胞斑的大小也显着减小。利巴韦林类似地减少了释放到培养上清液中的感染单位的数量。观察到抗病毒作用与病毒接种物的大小成反比,尽管所有浓度高于3.2微克的利巴韦林每毫升都明显降低了细胞病变的作用,而与接种物无关。以抑制浓度的病毒唑克隆呼吸道合胞病毒未能显示出对该药的耐药性增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号